Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Capital Leases (2016 - 2024)

iBio (IBIO) has disclosed Capital Leases for 9 consecutive years, with $53000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Capital Leases fell 84.9% to $53000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $53000.0, a 84.9% decrease, with the full-year FY2024 number at $53000.0, down 84.9% from a year prior.
  • Capital Leases was $53000.0 for Q2 2024 at iBio, down from $130000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $32.0 million in Q2 2020 to a low of $30000.0 in Q2 2022.
  • A 5-year average of $11.4 million and a median of $422000.0 in 2023 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: crashed 99.91% in 2022, then soared 1070.0% in 2023.
  • iBio's Capital Leases stood at $31.8 million in 2020, then plummeted by 99.84% to $51000.0 in 2021, then skyrocketed by 860.78% to $490000.0 in 2022, then crashed by 58.16% to $205000.0 in 2023, then tumbled by 74.15% to $53000.0 in 2024.
  • Per Business Quant, the three most recent readings for IBIO's Capital Leases are $53000.0 (Q2 2024), $130000.0 (Q1 2024), and $205000.0 (Q4 2023).